journal article·2019-12-04Open access

Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC

Wenbo Du, Ding Li, Xiaomin Guo, Ping Li, Xin Li, Shuping Tong, Junhui Tong, Lihua Kuang, Daoming Liang

Abstract

Our findings demonstrated that circ-PRMT5 function as an oncogene in GC patients by targeting miR-145/miR-1304/MYC axis. High circ-PRMT5 expression may provide a poor prognostic indicator of survival in GC patients and targeting circ-PRMT5/miR-145/miR-1304/MYC axis may be a novel therapeutic strategy for GC.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Circular RNAs in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastroenterology, The Affiliated Hospital of Inner Mongolia University for Nationalities

Department of General Surgery, Nantong Tumor Hospital

School of Mongol Medicine, Chuxiong Medical College

Academic Office, Hainan Medical University

School of Mongol Medicine, Inner Mongolia University for Nationalities

Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Inner Mongolia University for Nationalities

Department of Pharmacology, School of Pharmacy, China Medical University

Department of Internal Medicine, Shenzhen Pingle Orthopaedic Hospital

Department of Gastrointestinal Surgery, Kunming Medical University Second Hospital

References (34)

Show source-provided references
1. 10.3322/caac.2126210.3322/caac.21262 ↗
2. 10.1016/S0140-6736(14)62038-910.1016/S0140-6736(14)62038-9 ↗
3. 10.1093/jb/mvy07910.1093/jb/mvy079 ↗
4. 10.1016/j.gene.2015.02.00410.1016/j.gene.2015.02.004 ↗
5. 10.1053/j.gastro.2012.05.00310.1053/j.gastro.2012.05.003 ↗
6. 10.1371/journal.pgen.100377710.1371/journal.pgen.1003777 ↗
7. 10.1261/rna.035667.11210.1261/rna.035667.112 ↗
8. 10.1038/nature1192810.1038/nature11928 ↗
9. Cortes-Lopez M, Miura P. Emerging functions of circular RNAs. Yale J Biol Med. 2016;89(4):527–537.
10. 10.1242/dev.12807410.1242/dev.128074 ↗
11. 10.1038/nsmb.295910.1038/nsmb.2959 ↗
12. 10.1136/jmedgenet-2016-10375810.1136/jmedgenet-2016-103758 ↗
13. 10.1002/hep.2927010.1002/hep.29270 ↗
14. 10.1158/0008-5472.CAN-16-188310.1158/0008-5472.CAN-16-1883 ↗
15. 10.1038/onc.2017.8910.1038/onc.2017.89 ↗
16. 10.1016/j.canlet.2017.06.02710.1016/j.canlet.2017.06.027 ↗
17. 10.18632/oncotarget.346910.18632/oncotarget.3469 ↗
18. 10.1158/1078-0432.CCR-18-127010.1158/1078-0432.CCR-18-1270 ↗
19. 10.1093/nar/gkw02710.1093/nar/gkw027 ↗
20. Chaichian S, Shafabakhsh R, Mirhashemi SM, et al. Circular RNAs: a novel biomarker for cervical cancer. J Cell Physiol. 2019;234:11391–11400.
21. 10.1158/0008-5472.CAN-13-156810.1158/0008-5472.CAN-13-1568 ↗
22. 10.1186/s12943-017-0719-310.1186/s12943-017-0719-3 ↗
23. 10.1038/nature1199310.1038/nature11993 ↗
24. Reimondez-Troitino S, González-Aramundiz JV, Ruiz-Bañobre J, et al. Versatile protamine nanocapsules to restore miR-145 levels and interfere tumor growth in colorectal cancer cells. Eur J Pharm Biopharm. 2019;140:78–90.
25. 10.1177/096368971986106310.1177/0963689719861063 ↗
26. 10.3389/fonc.2019.0047710.3389/fonc.2019.00477 ↗
27. 10.1023/A:100701491900310.1023/A:1007014919003 ↗
28. 10.21873/anticanres.1265110.21873/anticanres.12651 ↗
29. 10.1016/j.bbrc.2019.03.21310.1016/j.bbrc.2019.03.213 ↗
30. 10.1016/j.bbrc.2019.01.10810.1016/j.bbrc.2019.01.108 ↗
31. 10.1016/S0065-230X(02)84004-010.1016/S0065-230X(02)84004-0 ↗
32. 10.1016/j.semcancer.2006.08.00310.1016/j.semcancer.2006.08.003 ↗
33. 10.1016/j.semcancer.2006.07.01510.1016/j.semcancer.2006.07.015 ↗
34. 10.1590/s1677-5538.ibju.2018.045010.1590/s1677-5538.ibju.2018.0450 ↗